1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 234 results for "Multiple Myeloma (MM)".

MM - 762

Secondary multiple myeloma and antecedent cancer lineage

Kirti Arora

Poster Presenter: Kirti Arora

MM - 766

Isatuximab-Carfilzomib-Dexamethasone Triplet Therapy: Real-World Data Based on the Hungarian Managed Access Program

Máté Huszár

Poster Presenter: Máté Huszár

$Thumbnail for Net Costs Associated With Inpatient Administration of Step-Up Dosing (SUD) of Bispecific Antibodies (bsAbs) Among Medicare Patients With Relapsed/Refractory Multiple Myeloma (MM)$

SOHO 2026 Annual Meeting

Topics

Secondary multiple myeloma and antecedent cancer lineage

Isatuximab-Carfilzomib-Dexamethasone Triplet Therapy: Real-World Data Based on the Hungarian Managed Access Program

Net Costs Associated With Inpatient Administration of Step-Up Dosing (SUD) of Bispecific Antibodies (bsAbs) Among Medicare Patients With Relapsed/Refractory Multiple Myeloma (MM)

Ciltacabtagene Autoleucel in Lenalidomide-Refractory Multiple Myeloma Responding to Bridging Therapy: CARTITUDE-4 Cytogenetic Subgroup Analysis

Updated Results From the Phase 2 IZALCO Study: Efficacy and Safety of Isatuximab Subcutaneous Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Rising Venous Thromboembolism-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 1999-2024: Pulmonary Embolism Burden and Demographic Disparities

Early Resolution of Talquetamab Oral Side Effects in Relapsed/Refractory Multiple Myeloma (RRMM): Updated Waterless Empirical Taste Test (WETT) and Patient Reported Outcomes (PRO) Data From TALisman

Treatment-Limiting On-Target Toxicity With Talquetamab/GPRC5D-Directed Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Correlation Between Mobilization Regimen and CD34? Stem Cell Yield in Multiple Myeloma (MM) Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT): A Single-Center Retrospective Analysis